(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)
Nov 18 (Reuters) - European stocks slipped on Wednesday as worries about further economic damage and fresh lockdown measures caused by a resurgent pandemic dented recent optimism over promising vaccine trial results.
The pan-European STOXX 600 extended losses for a second session after dropping 0.4% by 0805 GMT.
Real estate and energy stocks fell the most, while tech stocks advanced.
Britain’s RSA Insurance rose 3.8% to the top of the STOXX 600 index after the company said it had received a cash offer worth 7.2 billion pounds ($9.55 billion) from Canadian peer Intact Financial and Danish insurer Tryg .
Deutsche Boerse gained 0.8% after the German stock exchange operator said it would acquire an 80% stake in corporate governance adviser Institutional Shareholder Services (ISS) for about $1.8 billion. (Reporting by Shashank Nayar in Bengaluru, Editing by Sherry Jacob-Phillips)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.